nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cautionary case: osteoporotic femur fracture after robotic-assisted total knee arthroplasty
|
Skibicki, H. E. |
|
|
32 |
10 |
p. 2125-2129 |
artikel |
2 |
Alendronate use in older patients with reduced renal function: challenges and opportunities in clinical practice
|
Naganathar, N. |
|
|
32 |
10 |
p. 1981-1988 |
artikel |
3 |
An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines
|
Kanis, J. A. |
|
|
32 |
10 |
p. 1951-1960 |
artikel |
4 |
Association between outdoor particulate air pollution and the risk of osteoporosis: a systematic review and meta-analysis
|
Liu, JJ. |
|
|
32 |
10 |
p. 1911-1919 |
artikel |
5 |
Asymptomatic elevated parathyroid hormone level due to immunoassay interference
|
Zanchetta, M.B. |
|
|
32 |
10 |
p. 2111-2114 |
artikel |
6 |
Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review
|
Giannini, S. |
|
|
32 |
10 |
p. 1937-1949 |
artikel |
7 |
Clarification of some issues using Bayesian methods and model selection in meta-analysis and reporting
|
Wu, Q. |
|
|
32 |
10 |
p. 2137-2138 |
artikel |
8 |
Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05
|
Hagino, H. |
|
|
32 |
10 |
p. 2143 |
artikel |
9 |
Correction to: The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials
|
Su, S. |
|
|
32 |
10 |
p. 2141-2142 |
artikel |
10 |
Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan
|
Hagino, H. |
|
|
32 |
10 |
p. 2011-2021 |
artikel |
11 |
Denosumab is not associated with risk of malignancy? More evidence is needed
|
Zhao, J. |
|
|
32 |
10 |
p. 2133-2134 |
artikel |
12 |
Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials
|
Rosenberg, D. |
|
|
32 |
10 |
p. 2131 |
artikel |
13 |
Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis
|
Si, L. |
|
|
32 |
10 |
p. 2073-2081 |
artikel |
14 |
Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study
|
Tominaga, A. |
|
|
32 |
10 |
p. 1999-2009 |
artikel |
15 |
Efficiently stratifying mid-term death risk in femoral fractures in the elderly: introducing the ASAgeCoGeCC Score
|
Trevisan, C. |
|
|
32 |
10 |
p. 2023-2031 |
artikel |
16 |
Geographical variation in surgical care and mortality following hip fracture in England: a cohort study using the National Hip Fracture Database (NHFD)
|
Shah, A. |
|
|
32 |
10 |
p. 1989-1998 |
artikel |
17 |
Health care utilization and excess costs after pelvic fractures among older people in Germany
|
Andrich, S. |
|
|
32 |
10 |
p. 2061-2072 |
artikel |
18 |
Height loss in postmenopausal women—do we need more for fracture risk assessment? Results from the GO Study
|
Pluskiewicz, W. |
|
|
32 |
10 |
p. 2043-2049 |
artikel |
19 |
Higher latitude and lower solar radiation influence on hip fracture admissions in Chilean older population
|
Ormeño Illanes, J. C. R. |
|
|
32 |
10 |
p. 2033-2041 |
artikel |
20 |
High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs
|
Dussault, P.M. |
|
|
32 |
10 |
p. 2051-2059 |
artikel |
21 |
How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
|
Chevalley, T. |
|
|
32 |
10 |
p. 1921-1935 |
artikel |
22 |
Impact of population-based or targeted BMD interventions on fracture incidence
|
Harvey, N. C. |
|
|
32 |
10 |
p. 1973-1979 |
artikel |
23 |
Letter to the Editor about the article “C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches”
|
Bajpai, R. C. |
|
|
32 |
10 |
p. 2135-2136 |
artikel |
24 |
Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene
|
Datta, H.K. |
|
|
32 |
10 |
p. 2105-2109 |
artikel |
25 |
Physical capability, physical activity, and their association with femoral bone mineral density in adults aged 40 years and older: The Tromsø study 2015–2016
|
Hauger, A.V. |
|
|
32 |
10 |
p. 2083-2094 |
artikel |
26 |
Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy
|
Gu, K.D. |
|
|
32 |
10 |
p. 2119-2123 |
artikel |
27 |
Response to: “Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature”
|
Samalia, Priya |
|
|
32 |
10 |
p. 2139 |
artikel |
28 |
Risk factors for multi-joint disease in patients with glucocorticoid-induced osteonecrosis
|
Krez, A. |
|
|
32 |
10 |
p. 2095-2103 |
artikel |
29 |
Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report
|
Kim, J.-T. |
|
|
32 |
10 |
p. 2115-2118 |
artikel |
30 |
The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications
|
Skjødt, M. K. |
|
|
32 |
10 |
p. 1961-1971 |
artikel |